Class of Stock [Axis] Common Stock, $0.0001 par Value per Share [Member] Warrants each Exercisable for One Share of Common Stock for 575 per Share [Member] Related and Nonrelated Parties [Axis] Related Party [Member] Series A Preferred Stock [Member] Series C Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Series B Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Sales Agreement [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Warrant [Member] Measurement Input Type [Axis] Measurement Input, Option Volatility [Member] Measurement Input, Discount Rate [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 1 [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Loan Agreement [Member] The Patel Family LLP [Member] Long-Term Debt, Type [Axis] Unsecured Debt [Member] Award Type [Axis] February to March 2030 [Member] Sale of Stock [Axis] Additional Amount Purchase Option [Member] Polar Multi Strategy Master Fund [Member] Plan Name [Axis] 2024 Plan [Member] Restricted Stock Units (RSUs) [Member] Title and Position [Axis] Chief Executive Officer [Member] Service based Restricted Stock and RSU [Member] Performance-Based RSUs [Member] Service-Based Restricted Stock [Member] Location, Statement of Income, Balance [Axis] Semper Paratus [Member] Private Placement [Member] Antidilutive Securities [Axis] Restricted Stock [Member] Earnout Shares [Member] Sponsor [Member] Sponsor Advisory Services Fee [Member] Dr. Manmohan Patel [Member] Scenario [Axis] Immediate [Member] January 2025 [Member] February 2025 [Member] KRHP LLC [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Assets Current assets: Cash Prepaid expenses and other assets Due from related party Total current assets Property and equipment, net Right-of-use assets - operating leases Deferred transaction costs Other assets Total assets Liabilities and stockholders’ deficit Current liabilities: Accounts payable Accrued expenses and other liabilities Operating lease liabilities Notes payable Due to related party Total current liabilities Loan agreement Operating lease liabilities Derivative warrant liabilities Total liabilities Stockholders’ deficit Preferred Stock, value Common stock, $0.0001 par value; 800,000,000 shares authorized; 4,168,705 and 4,020,746 shares issued and outstanding at March 31, 2026 and December 31, 2025 Additional paid-in capital Accumulated deficit Total stockholders’ deficit Total liabilities and stockholders’ deficit Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Preferred stock, liquidation value Common shares, par value Common shares, shares authorized Common shares, shares issued Common shares, shares outstanding Income Statement [Abstract] Operating expenses: Research and development General and administrative Total operating expenses Loss from operations Interest expense, net Change in fair value of warrants Net loss Net loss attributable to common stockholders, diluted Net loss attributable to common stockholders, basic Net loss per share attributable to common stockholders, basic Net loss per share attributable to common stockholders, diluted Weighted-average common stock outstanding, basic Weighted-average common stock outstanding, diluted Beginning balance, value Beginning balance, shares Issuance of common stock in settlement of vested restricted stock units Issuance of common stock in settlement of vested restricted stock units, shares Issuance of shares under the sales agreement, net of issuance costs Issuance of shares under the sales agreement, net of issuance costs, shares Stock-based compensation Net loss Loan Agreement interest settled in stock Capital contribution Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation expense Stock-based compensation expense Non-cash interest expense Change in fair value of warrants Amortization of right-of-use asset Change in operating assets and liabilities: Prepaid expenses and other assets Other assets Accounts payable Accrued expenses and other liabilities Operating lease liabilities Net cash used in operating activities Cash flows from investing activities: Net cash used in investing activities Cash flows from financing activities: Proceeds from loan agreement Proceeds from issuance of shares under the sales agreement, net of offering costs Capital contribution Net cash provided by financing activities Net increase in cash Cash - beginning of period Cash - end of period Supplementary disclosure of noncash investing and financing activities: Deferred offering cost amortization Receivables from issuance of shares under the sales agreement Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Equity Awards Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Accounting Policies [Abstract] NATURE OF BUSINESS Development-stage Risks And Liquidity DEVELOPMENT-STAGE RISKS AND LIQUIDITY SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Payables and Accruals [Abstract] ACCRUED EXPENSES AND OTHER LIABILITIES Debt Disclosure [Abstract] DEBT Share-Based Payment Arrangement [Abstract] STOCK-BASED COMPENSATION Equity [Abstract] STOCKHOLDERS’ DEFICIT Earnings Per Share [Abstract] NET LOSS PER SHARE Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Segment Reporting [Abstract] SEGMENT REPORTING Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Fair Value Measurements Net Loss Per Share Recently Issued Accounting Standards SCHEDULE OF FAIR VALUES OF WARRANTS SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON RECURRING BASIS SCHEDULE OF ACCRUED EXPENSES AND OTHER LIABILITIES SCHEDULE OF RESTRICTED STOCK AND RSU ACTIVITY SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE SCHEDULE OF RECONCILIATION OF SHARES OF COMMON STOCK ISSUED AND OUTSTANDING SCHEDULE OF RECONCILIATION OF NET LOSS SCHEDULE OF ANTI-DILUTIVE NET LOSS PER SHARE Reverse stock split ratio Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Aggregate purchase price Net proceeds from sale of common stock Remaining commitment AccountingPoliciesTable [Table] Business Combination [Line Items] Changes in fair value of derivative liabilities Fair value of written call options Free standing purchase options Embedded options Share price Alternative investment measurement input Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] Derivative warrant liabilities, Balance Change in fair value Derivative warrant liabilities, Balance Professional services Other Total Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Line of credit maximum borrowing capacity Line of credit borrowing capacity Line of credit Line of credit remaining capacity Option to purchase common stock, value Percentage of price of common stock purchased Purchase, price per share Derivative liability Derivative liabilities, current Common stock fair value notes payable Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Nonvested Shares, Outstanding Nonvested weighted average grant-date fair value, Outstanding Nonvested Shares, Granted Nonvested weighted average grant-date fair value, Granted Nonvested Shares, Vested Nonvested weighted average grant-date fair value, Vested Nonvested Shares, Forfeited Nonvested weighted average grant-date fair value, Forfeited Nonvested Shares, Outstanding Nonvested weighted average grant-date fair value, Outstanding Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Total Compensation shares authorized Shares available to be granted Grant date fair value of shares Number of shares issued for RSUs Number of shares issued for granted Fair value per share for award Compensation cost Unrecognized compensation cost Weighted average period for recognition Total shares of common stock outstanding Vested RSUs not yet legally settled into common stock Issuance of restricted common stock subject to forfeiture Total shares issued and outstanding Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] Number of warrants outstanding Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Preferred stock dividend Net loss attributable to common stockholders Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total Stock option vested Related Party Transaction [Table] Related Party Transaction [Line Items] Sponsor advisory service fee Sponsor advisory services fee payable Sponsor fee payable offset Number of shares issued for sponsor fees Due from related party Granted, shares Vested shares Aggregate grant date fair value Grant fair value Additional grant funding Number of operating segment Subsequent Event [Table] Subsequent Event [Line Items] Number of common stock purchase warrants shares Warrants each Exercisable for One Share of Common Stock for 575 per Share [Member] Common Stock, $0.0001 par Value per Share [Member] Loan agreement non current. Development Stage Risks And Liquidity [Text Block] Sales Agreement [Member] Stock issued during period value settlement of vested restricted stock units. Stock issued during period shares settlement of vested restricted stock units. Free standing purchase options. Embedded options. Loan agreement interest settled in stock. Loan Agreement [Member] The Patel Family LLP [Member] Additional Amount Purchase Option [Member] Stock issued during period shares commitment shares in connection with unsecured equity line of credit facility. Polar Multi Strategy Master Fund [Member] 2024 Plan [Member] Deferred offering cost amortization. Receivables from issuance of shares under the sales agreement. Service-Based Restricted Stock [Member] Performance-Based RSUs [Member] Sponsor advisory services fee payable. Sponsor [Member] Service based Restricted Stock and RSU [Member] Sponsor Advisory Services Fee [Member] Dr Manmohan Patel [Member] KRHP LLC [Member] Vested performance based restricted stock units from satisfaction of liquidity condition upon closing. Shares subject to future vesting issuance of restricted common stock subject to forfeiture. Common stock shares issued and outstanding inclusion of shares to be issued and exclusion of shares subject to forfeiture. Semper Paratus [Member] Fair value of written call options. February to March 2030 [Member] Immediate [Member] January 2025 [Member] February 2025 [Member] Earnout Shares [Member] Assets, Current Assets [Default Label] Liabilities, Current Operating Lease, Liability, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Shares, Outstanding Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Other Operating Assets Increase (Decrease) in Accounts Payable, Trade Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Operating Lease Liability Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Proceeds from Contributed Capital Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Preferred Stock Dividends, Income Statement Impact Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Other Receivables